CHRISTINA KRAINBRINK: Open Payments
NPI 1902410830 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,209 in 101 payments from 19 companies in 2025. Trend: 2023 $1,771 · 2024 $1,543 · 2025 $2,209
Food & beverage: $2,110Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $614 |
| Madrigal Pharmaceuticals | 12 | $405 |
| Janssen Biotech, Inc. | 9 | $219 |
| QOL Medical, LLC | 8 | $175 |
| Lilly USA, LLC | 6 | $147 |
| Exact Sciences Corporation | 1 | $86 |
| Ipsen Biopharmaceuticals, Inc | 4 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $73 |
| GENZYME CORPORATION | 3 | $69 |
| Gilead Sciences, Inc. | 2 | $60 |
Products named: REZDIFFRA, RINVOQ, TREMFYA, Sucraid, OMVOH, SKYRIZI, LINZESS, The Cologuard Plus Collection Kit.
Industry payments across NV — which companies pay providers there.
